Friday, February 06, 2026

"ambiguity" is taking hold in consumer protection class actions, but it's not the Lanham Act concept

Ramirez v. S. Martinelli & Co., 2026 WL 272621, No. 25-cv-07569-NC (N.D. Cal. Feb. 2, 2026)

Martinelli’s apple juice products’ front labels state either “Premium 100% Juice Not From Concentrate” or “100% Juice From U.S. Grown Fresh Apples.” The products now contain ascorbic acid, a preservative, listed in the ingredients on the products’ back labels. Martinelli allegedly intentionally designed the products’ labeling so they appear to contain only juice because consumers are willing to pay more for a product without additives, and charges roughly fifty percent more than comparators. FDA and state law allegedly requires “with added preservatives” on the front label.

Plaintiffs brought NY and California statutory claims, which the court declined to dismiss.

The court found deception plausible: “Premium 100% Juice Not From Concentrate” and “100% Juice from U.S. Grown Fresh Apples” were “likely to deceive a reasonable consumer into believing that the products contain only apple juice, without other ingredients. That is, reasonable consumers could see the front label as making an unambiguous representation which would not require further information.”

Under consumer protection precedents, “[j]ust because the labels are subject to two reasonable interpretations—that the product is 100% juice, or that the juice is 100% from fresh apples/not from concentrate—does not make it ambiguous” such that a reasonable consumer is required to consult the back label.  Instead, the labels could be “unambiguously deceptive to an ordinary consumer, such that the consumer would feel no need to look at the back label.” 

[I think it’s bad to have two different definitions of “unambiguous,” one for competitors and one for consumers, applied to the same “false advertising” concept, especially since none of the courts I’ve seen have acknowledged this difference or given a theoretical justification therefor. These conflicting definitions are inevitably going to cause legal confusion. “Plausibly sufficient to convey a specific false message, without the consumer needing to check for more information” might be better than “unambiguous” for the consumer protection class action context; it much better captures the concept although it is of course longer.]

Nor did the claims rest solely on a violation of federal law: the front labels were plausibly misleading and the plaintiffs alleged reliance and resulting injury.

The court did kick out a punitive damages request, but not warranty/unjust enrichment claims or a request for injunctive relief.


conducting dueling internet searches converts attys into fact witnesses in TM case

Vicious Brands, Inc. v. Face Co., No. 24-cv-04996-LJC, 2026 WL 276178 (N.D. Cal. Feb. 3, 2026) (magistrate)

Plaintiff, aka Saints & Sinners, sued Face, aka Skin Saint, alleging trademark infringement and false advertising. The court granted the motion to dismiss the false advertising claims but denied summary judgment on trademark infringement, except for reverse confusion, reflecting the higher barriers to false advertising claims.

Plaintiff has sold Saints & Sinners haircare products since 2016, using a mark that includes two horizontally conjoined instances of the letter S:



It has registrations including that mark.

Defendants sell beauty consultation services and skincare products under the Skin Saint trade name, using a mark that consists of two vertically conjoined instances of the letter S:

They began using it in 2021; Saints & Sinners first learned of it in 2023. “Defendants sell their products through a physical location in Michigan and, to a lesser extent, nationally through their website” and through shop.app. They promote themselves on social media and some national television appearances.

Saints & Sinners alleged that it has been planning to expand into skincare.

False advertising: Saints & Sinners alleged that “Defendants have engaged in false advertising by making misleading and deceptive claims about their products in commercial advertisements and promotions, including representations that their products are medical grade, provide anti-aging results equivalent to that of medical cosmetic treatments like injectable fillers and toxins, and reverse/prevent aging changes in the skin.”

But Saints & Sinners didn’t have standing because there was no imminent injury. (Why is there standing to claim trademark infringement, then? Sigh.)

It alleged that it was “ready to launch its skincare line upon finalization of product attributes and regulatory review,” and that its products would “directly compete with the serums, creams, and other topical formulations marketed and sold under Defendants’ brand … namely: cleanser; moisturizer; creams; cleansers [sic]; toners; masks; skin treatments; and serums, all in Class 3.” It also alleged that both parties sell through e-commerce to the same general consumer demographics seeking moisturizing, antioxidant, and anti-aging skincare products, targeting the same customer demographics— “customers seeking luxury and performance skincare products”—and sold through overlapping channels, including online retail/ecommerce platforms like Amazon.

The Supreme Court has “repeatedly reiterated that threatened injury must be certainly impending to constitute injury in fact, and that allegations of possible future injury are not sufficient.” In Lanham Act cases, the Ninth Circuit has “generally presumed commercial injury when defendant and plaintiff are direct competitors and defendant’s misrepresentation has a tendency to mislead consumers.” A plaintiff can meet that burden “using actual market experience and probable market behavior,” which in the absence of “lost sales data” might be done by “creating a chain of inferences showing how defendant’s false advertising could harm plaintiff’s business.” At issue here was “harm to reputation or sales, which generally arises from direct competition.”

For Article III, the court pointed to the classic Lujan case, where environmental plaintiffs’ “mere profession of an intent, some day, to return” to sites allegedly harmed by the challenged projects was insufficient to satisfy Article III’s injury requirement. As there, “the plaintiff alleges only an injury at some indefinite future time, and the acts necessary to make the injury happen are at least partly within the plaintiff’s own control.”

In Tercica, Inc. v. Insmed Inc., No. C 05-5027 SBA, 2006 WL 1626930 (N.D. Cal. June 9, 2006), the court found false advertising standing against an intended competitor in the pharmaceutical industry where the plaintiff had obtained “FDA approval ... and product distribution [was] likely imminent.” And courts and commentators have stated that “actively preparing to produce the article in question” is sufficient as “the last point before the point of no return” in the context of declaratory judgments. But this wasn’t a declaratory judgment case where the plaintiff would otherwise risk infringement liability. “So long as there are necessary steps beyond Plaintiff’s control, or doubt as to if or when a competing product will actually come to market, Plaintiff has alleged only ‘possible future injury’ as a result of Defendants’ purportedly false advertising, rather than the ‘certainly impending’ injury necessary ‘to constitute injury in fact.’” The allegations here indicated that Saints & Sinners’ products remain subject to “finalization of product attributes and regulatory review” before they come to market, “raising questions of whether their launch could still be derailed.”

This analysis also applied to statutory standing under Lexmark. The court did, however, reject any suggestion that a competitor in a “market [with] numerous participants” lacks a sufficient expectation of “ ‘automatically’ displace[d]” sales to support standing under the Lanham Act— “a premise that would seem to preclude most if not all Lanham Act false advertising claims in typical markets with multiple competitors.” The allegations of the complaint were sufficient to support a plausible inference that, if or when Sinners & Saints products come to market, at least some of them will compete directly with at least some of defendants’ products. Leave to amend granted.

Trademark/summary judgment: I gotta admit, this one seems extremely thin to me, but nonetheless the parties must proceed on the forward confusion theory.

Plaintiff’s double-S mark appears on many (perhaps all) of its products, typically with the double-S mark positioned above Saints & Sinners, which is in turn positioned above a product title. The product packaging tends to be a solid color or gradient, with the mark and text generally displayed in monochrome white, silver, or black. Saints & Sinners products are mostly sold at suggested retail prices ranging from $20 to $95, and in third-party beauty subscription boxes. And, as discussed, Saints & Sinners planned to expand.

Skin Saint’s founder testified at a deposition that she used a “logo generator” to develop a new mark in 2020, and settled on the double-S mark because it was visually appealing and resembled her logo for her related FACE clinic, which “is a wave with an F.” She did not research whether the mark was similar to other marks used by other companies. Skin Saint’s products often display their double-S mark positioned vertically above the words “SKIN SAINT,” in turn above a product name or description. The packaging is white and the mark and text are black. Since they began using the accused mark in 2021, defendants have sold significantly more Skin Saint products through their clinic than through their website.

Saints & Sinners learned of Skin Saint’s mark from a trademark watch report that characterized defendants’ mark as having a “Low risk” of conflict with plaintiff’s mark. Plaintiff nonetheless opposed, which is ongoing.

Plaintiff’s counsel offered “screenshots of searches [he] personally conducted on the SHOP.app website” that show some of defendants’ products among search results for the search query “Saints and Sinners skincare” and other similar queries. But defense counsel was unable to replicate those results and did not find any of defendants’ products when running the same searches on Shop.app. (Hmm… a personalized algorithm might be doing this if, as is plausible, plaintiff’s counsel had sought out defendants’ products before.) Defendants’ sales through Shop.app were 28 orders for a total of $2,468 in the first ten months of 2025 and less in 2024.

There was no evidence of actual confusion or other harm. “A Google search for either party’s name does not return the other party’s website or products in the first ten pages of results.” Several other skincare and haircare brands use marks with a double S, but none use “saint” or “sinner” in their trade names.

Saints & Sinners also submitted an expert declaration from “a beauty industry consultan[t] specializing in market strategy and consumer behavior across skincare, haircare, and adjacent personal care categories” who opined that haircare and skincare markets were converging to focus on scalp care (the “skinnification” of hair), that impulse buying of beauty products in the social media era was common, and that consumer confusion was likely, although the court didn’t rely on that last for its summary judgment ruling.  

As for those searches on shop.app: “Whether intentionally or not, both parties’ attorneys have made themselves fact witnesses, and the Court now orders that the parties may take their depositions regarding the limited issue of their Shop.app searches within the time that the parties have reserved for other specific depositions.” The court wouldn’t disregard either parties’ attorneys’ searches. [Not sure depositions would help if the issue is algorithms! Bringing in the specific computers, or at least logging in as the specific attorneys, might do more.]

Basically, the multifactor confusion inquiry means that it’s hard to grant summary judgment for defendants. Unfortunately, along with deeming the double-S logo arbitrary and possessed of some commercial strength, the court also quoted out-of-circuit precedent that incontestable registrations “are presumed to be strong marks.” [I didn't pull the registrations--but the description that the registrations "include" rather than consist of the double-S would also cut against this conclusion, since what is incontestable is the registration as a whole, not parts of it.]

For reverse confusion, though, “Defendants’ relatively modest sales—at least on the scale of the national skincare or beauty market as a whole—undermine any implication that Defendants pose a serious risk of dominating the public’s perception of the market.”

And, though the parties’ “marks have meaningful differences, such that someone comparing them side by side would never consider them to be the same mark,” there was enough similarity to go to a jury, even though it was perhaps “a close call,” given the parties’ monochromatic color palettes and overlapping use of “saint.”

And, even if a lack of survey evidence should be presumed to favor the defendant, “whether a presumption has been overcome is normally a question for the jury.” [I think this presumption is best applied to large companies with large litigation budgets: if P&G doesn’t submit a survey, we can infer that it expected bad results. I don’t think it’s a good idea to disregard the absence of a survey in all summary judgment contexts, but the court here does because it focuses on the Ninth Circuit’s caution that summary judgment is disfavored in trademark infringement cases.]

Likewise, the court discounted the absence of any actual confusion evidence because the parties weren’t in “direct local competition over a period of several years.” “It remains possible that consumers have confused the two marks, and either purchased or declined to purchase products based on that mistake, without alerting either party to their having done so.” How is the jury to assess this possibility in assessing likelihood?